Top Reasons to Ditch Your Current VTM.…
READ MOREA deadly fungal infection, Candida Auris, is becoming a serious threat. This drug-resistant strain is deadly for those with weakened immune systems and is spreading at an alarming rate. The iSWAB-Microbiome-EL has been proven to safely collect and transport samples suspected of containing the infection and has…
READ MOREAppreciating Women in STEM
The month of March is National Women’s Month and Mawi DNA is celebrating the amazing women on our team that are bringing innovation to life. Our diverse team comes together everyday to push the boundaries of continuously innovating biosampling collection technology. At Mawi DNA the…
READ MOREInnovate Further with High Quality DNA Samples
iSWAB™-DNA Quick Facts Gentle lytic buffer Non-Toxic and alcohol-free device High recovery of high molecular weight gDNA Insignificant quantities of bacterial DNA contamination Compatible with microarrays and Next Generation Sequencing Stable at room temperature for ~3 years The Mawi team is here to contribute to your…
READ MOREThe Safest Microbial Buffer on the Market
The iSWAB™-Microbiome (iSWAB™-MB) is a non-toxic, stabilizing sample device designed to maintain the status quo of samples at the time of collection, providing a representative snapshot of the microbial community that remains unchanged from the point of collection to processing.
READ MOREMawi DNA Awarded Leading Innovators of Biosample Collection Technology 2022
The Global Health & Pharma (GH&P) Magazine awarded Mawi DNA Technologies with the 2022 Leading Innovators of Biosample Collection Technology Award. Mawi DNA is honored to be recognized for this achievement and continues to develop innovative technologies for universal sample collection. “I strongly believe that science is…
READ MOREAnnouncing Mawi DNA’s Joint venture with our local partner BIOTESSIA to establish a state-of-the-art manufacturing facility in Morocco to serve the African market.
Announcing Mawi DNA's joint venture with BIOTESSIA to establish a state-of-the-art manufacturing facility in Morocco to serve the African market. This will be accomplished via the unique and innovative biosampling technology set forth by Mawi DNA. BIOTESSIA's strategy and vision are centered around ensuring health needs…
READ MOREAchieve faster, more accurate COVID-19 results with the NextSWAB
Testing for infectious disease SARS-CoV-2 using the NextSWAB 100% medical-grade plastic molded swab – outperforms flocked swabs in many applications Mawi DNA Technologies, a biotechnology company focusing on the development of innovative technologies for biosampling, announces its launch of a new product in response to…
READ MOREMawi DNA Technologies Awarded Two ISO Certifications
Hayward, CA - February 9, 2022 – Mawi DNA Technologies (Mawi), a leading biosampling collection company, announces it has been awarded the ISO 9001:2015 Quality Management Systems and ISO 13485:2016 Medical Devices Quality Management Systems certifications. Mawi developed and commercialized the iSWAB technology, an innovative…
READ MOREMawi maintains robust stock of COVID testing supplies with USA-Based, uninterrupted supply chain.
Mawi’s iSWAB technology is available in various quantities to support large and small COVID testing sites with no supply chain delays. We are proud to say that over the course of this pandemic we have never experienced supply chain issues. We have full control over…
READ MOREiSWAB Microbiome collection media approved for home collection of COVID-19 samples; Mawi maintains robust stock of testing supplies
The University of California, San Diego (UCSD) EXCITE lab has been extensively using Mawi’s iSWAB-Microbiome technology for campus and community surveillance. Mawi DNA Technologies is honored to announce the FDA has granted Emergency Use Authorization (EUA) for UCSD Excite Lab’s COVID test, submitted with iSWAB-Microbiome…
READ MORE